US Bancorp’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $223 | Sell |
31
-195
| -86% | -$1.4K | ﹤0.01% | 4062 |
|
|
2025
Q1 | $1.35K | Buy |
+226
| New | +$1.35K | ﹤0.01% | 3923 |
|
|
2024
Q3 | – | Sell |
-137
| Closed | -$1.16K | – | 4076 |
|
|
2024
Q2 | $1.16K | Buy |
+137
| New | +$1.16K | ﹤0.01% | 3772 |
|
|
2023
Q4 | – | Sell |
-245
| Closed | -$2.39K | – | 3972 |
|
|
2023
Q3 | $2.39K | Sell |
245
-188
| -43% | -$1.83K | ﹤0.01% | 3600 |
|
|
2023
Q2 | $5.13K | Sell |
433
-2,811
| -87% | -$33.3K | ﹤0.01% | 3439 |
|
|
2023
Q1 | $35K | Sell |
3,244
-498
| -13% | -$5.37K | ﹤0.01% | 2690 |
|
|
2022
Q4 | $43.3K | Buy |
3,742
+1,518
| +68% | +$17.5K | ﹤0.01% | 2606 |
|
|
2022
Q3 | $33K | Buy |
2,224
+923
| +71% | +$13.7K | ﹤0.01% | 2760 |
|
|
2022
Q2 | $12K | Buy |
+1,301
| New | +$12K | ﹤0.01% | 3277 |
|
|
2021
Q3 | – | Sell |
-61
| Closed | – | – | 4046 |
|
|
2021
Q2 | $0 | Buy |
+61
| New | – | ﹤0.01% | 3978 |
|